Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thoracic Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Patient Acceptance of Health Care 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Lung Diseases 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Large Cell 1Cancer Therapy-related Cardiovascular Toxicity 1Breast Neoplasm Female 1

Interventions

tocilizumab 1Probiotics 1Paclitaxel 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Cancer Therapy-related Cardiovascular Toxicity × Paclitaxel × Clear all
NCT05730777 2023-02-16

Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics

Peking University Third Hospital

Phase 4 Unknown
200 enrolled

Cancer Therapy-related Cardiovascular Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡